These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16492081)

  • 21. FDA approval of paroxetine for menopausal hot flushes.
    Orleans RJ; Li L; Kim MJ; Guo J; Sobhan M; Soule L; Joffe HV
    N Engl J Med; 2014 May; 370(19):1777-9. PubMed ID: 24806158
    [No Abstract]   [Full Text] [Related]  

  • 22. On the therapeutic action of SSRI medications.
    Sandberg LS
    J Am Psychoanal Assoc; 2004; 52(2):490-1; author reply 493-8. PubMed ID: 15222456
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA warning to manufacturers of AIDS drugs.
    Josefson D
    BMJ; 2001 May; 322(7295):1143. PubMed ID: 11348904
    [No Abstract]   [Full Text] [Related]  

  • 24. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auditory measures in clinically depressed individuals. I. Basic measures and transient otoacoustic emissions.
    Gopal KV; Carney L; Bishop CE
    Int J Audiol; 2004 Oct; 43(9):493-8. PubMed ID: 15726839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the therapeutic action of SSRI medications.
    Levinson MH
    J Am Psychoanal Assoc; 2004; 52(2):483-6; author reply 493-8. PubMed ID: 15222453
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serotonin neurotrasmission and treatment options for depression].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new antidepressant.
    Glazer WM
    Behav Healthc; 2011 Sep; 31(6):39-40. PubMed ID: 22026116
    [No Abstract]   [Full Text] [Related]  

  • 30. [New perspectives in the serotoninergic treatment for depression].
    Hamon M
    Therapie; 1995; 50(6):505-9. PubMed ID: 8745948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the increase in LDL cholesterol induced by selective serotonin reuptake inhibitor therapy a blessing in disguise?
    Goldstein MR; Mascitelli L; Pezzetta F
    Med Hypotheses; 2010 May; 74(5):955-6. PubMed ID: 20031337
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychopharmacology. Volatile chemistry: children and antidepressants.
    Couzin J
    Science; 2004 Jul; 305(5683):468-70. PubMed ID: 15273374
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective serotonin-reuptake inhibitors and recovery after stroke.
    Robinson RG; Adams HP
    Lancet Neurol; 2011 Feb; 10(2):110-1. PubMed ID: 21216671
    [No Abstract]   [Full Text] [Related]  

  • 34. Vilazodone approved for major depression.
    Traynor K
    Am J Health Syst Pharm; 2011 Mar; 68(5):366. PubMed ID: 21330672
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple serotonergic paths to antidepressant efficacy.
    Lutz PE
    J Neurophysiol; 2013 May; 109(9):2245-9. PubMed ID: 23343901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic considerations for serotonin reuptake inhibitor use by aviators.
    Ireland RR
    Aviat Space Environ Med; 2002 May; 73(5):421-9. PubMed ID: 12014600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
    Koren G; Matsui D; Einarson A; Knoppert D; Steiner M
    CMAJ; 2005 May; 172(11):1457-9. PubMed ID: 15911861
    [No Abstract]   [Full Text] [Related]  

  • 38. Depression and serotonin: a never ending story.
    Marazziti D
    Curr Drug Targets; 2013 May; 14(5):513. PubMed ID: 23547753
    [No Abstract]   [Full Text] [Related]  

  • 39. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
    Nair GV; Gurbel PA; O'Connor CM; Gattis WA; Murugesan SR; Serebruany VL
    Am J Cardiol; 1999 Aug; 84(3):321-3, A8. PubMed ID: 10496443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monoaminergic selectivity of the antidepressive drugs and sleep: neurophysiological implications of depression].
    Lorenzo JL; Barbanoj MJ
    Rev Neurol; 2000 Jan 16-31; 30(2):191-4. PubMed ID: 10730330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.